Tag Archives: COVID19

New studies are estimating spending on COVID-19

In a new report published by the Brookings Institution, Matthew Fiedler, Ph.D. ’13 , a fellow in economic studies at the USC-Brookings Schaeffer Initiative for Health Policy, and Zirui Song, M.D. ’10, Ph.D. ’12, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, estimate national health care spending for COVID-19 care and… Read More »

Covid-19 Patient Gets Double Lung Transplant, Offering Hope for Others

A young woman whose lungs were destroyed by the coronavirus received a double lung transplant last week at Northwestern Memorial Hospital in Chicago, the hospital reported on Thursday, the first known lung transplant in the United States for Covid-19. The 10-hour surgery was more difficult and took several hours longer than most lung transplants because… Read More »

Testing Sewage Sludge May Predict COVID-19 Outbreaks

Wastewater treatment has been a focus of environmental protection groups for years since the plants are not equipped to treat wastewater containing products of modern life, including toxic chemicals, drugs and cosmetics. It wasn’t until 1972 when the Clean Water Act1 was passed that pollution discharged into U.S. waterways began to be regulated. The Act… Read More »

Black Americans Report Worse Effects of Bias From COVID-19

A new poll by Axios-Ipsos, the world’s third-largest market research company, shows that Black Americans are more concerned about the pandemic’s impact on their lives than white Americans. The poll found that African Americans report that they have been impacted differently and generally worse by the COVID-19 pandemic. For example, nearly 30% of Black Americans… Read More »

Authors retract Lancet article that found hydroxychloroquine increases risk of death in COVID-19 patients

NEW YORK — An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients was retracted on Thursday, adding to the controversy around a drug championed by U.S. President Donald Trump. Three of the authors of the article retracted it, citing concerns about the quality and veracity of data in… Read More »